Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125007303 | 12500730 | 3 | F | 20160606 | 20160701 | 20160627 | 20160713 | EXP | KR-CELGENEUS-KOR-2016063823 | CELGENE | 52.85 | YR | M | Y | 50.10000 | KG | 20160713 | OT | KR | KR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125007303 | 12500730 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Other | U | 21660 | 196 | MG/M**2 | INJECTION FOR INFUSION | |||||||
| 125007303 | 12500730 | 2 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | 0 | 1570 | MG/M**2 | INJECTION FOR INFUSION | |||||||
| 125007303 | 12500730 | 3 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | Unknown | 560 MILLIGRAM | 0 | UNKNOWN | |||||||||
| 125007303 | 12500730 | 4 | C | NAPROXEN. | NAPROXEN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125007303 | 12500730 | 5 | C | gabapentin C | 2 | Unknown | 0 | UNKNOWN | |||||||||||
| 125007303 | 12500730 | 6 | C | MAGNESIUM HYDROXIDE. | MAGNESIUM HYDROXIDE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125007303 | 12500730 | 1 | Pancreatic carcinoma metastatic |
| 125007303 | 12500730 | 2 | Pancreatic carcinoma metastatic |
| 125007303 | 12500730 | 3 | Product used for unknown indication |
| 125007303 | 12500730 | 4 | Product used for unknown indication |
| 125007303 | 12500730 | 5 | Product used for unknown indication |
| 125007303 | 12500730 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125007303 | 12500730 | HO |
| 125007303 | 12500730 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125007303 | 12500730 | Neutropenia | |
| 125007303 | 12500730 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125007303 | 12500730 | 1 | 20160518 | 20160615 | 0 | |
| 125007303 | 12500730 | 2 | 20160518 | 20160615 | 0 | |
| 125007303 | 12500730 | 3 | 20160502 | 0 | ||
| 125007303 | 12500730 | 4 | 20160518 | 0 | ||
| 125007303 | 12500730 | 5 | 20160518 | 0 | ||
| 125007303 | 12500730 | 6 | 20160518 | 0 |